These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10503157)

  • 21. Technology assembly in managed care.
    Tanenbaum SJ
    J Health Polit Policy Law; 1999 Aug; 24(4):759-62. PubMed ID: 10503156
    [No Abstract]   [Full Text] [Related]  

  • 22. Reimbursement disputes involving experimental medical treatment.
    Molino PJ
    J Health Hosp Law; 1991 Nov; 24(11):329-36, 343, 359. PubMed ID: 10114834
    [No Abstract]   [Full Text] [Related]  

  • 23. Invention to practice.
    Hillman BJ
    J Am Coll Radiol; 2006 Sep; 3(9):643-4. PubMed ID: 17412143
    [No Abstract]   [Full Text] [Related]  

  • 24. Medicare and cost-effectiveness analysis.
    Neumann PJ; Rosen AB; Weinstein MC
    N Engl J Med; 2005 Oct; 353(14):1516-22. PubMed ID: 16207857
    [No Abstract]   [Full Text] [Related]  

  • 25. HTA Around the World: Broadening Our Understanding of Cross-Country Differences.
    Torbica A
    Value Health; 2020 Jan; 23(1):1-2. PubMed ID: 31952663
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental or conventional? Ask a judge.
    Moskowitz DB
    J Am Health Policy; 1992; 2(1):53-6. PubMed ID: 10116484
    [No Abstract]   [Full Text] [Related]  

  • 27. Rising costs of Medicare may cause medical care rationing for elderly.
    Strasser AL
    Occup Health Saf; 1989 Sep; 58(10):62. PubMed ID: 2507989
    [No Abstract]   [Full Text] [Related]  

  • 28. Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.
    Tsoi B; O'Reilly D; Masucci L; Drummond M; Goeree R
    J Popul Ther Clin Pharmacol; 2015; 22(1):e78-89. PubMed ID: 25715384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of medical technology policies shows need, opportunities for changes.
    Banta D
    Hospitals; 1982 Apr; 56(7):87-90. PubMed ID: 6800914
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigational treatments: coverage, controversy, and consensus.
    Ader M
    Ann Health Law; 1996; (5):45-60. PubMed ID: 10164521
    [No Abstract]   [Full Text] [Related]  

  • 31. Defining experimental therapy--a third-party payer's dilemma.
    Newcomer LN
    N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
    [No Abstract]   [Full Text] [Related]  

  • 32. Can the NICE "end-of-life premium" be given a coherent ethical justification?
    Cookson R
    J Health Polit Policy Law; 2013 Dec; 38(6):1129-48. PubMed ID: 23974470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical innovation duels cost containment.
    Rettig RA
    Health Aff (Millwood); 1994; 13(3):7-27. PubMed ID: 7927162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for outcomes research in radiology and health policy.
    McNeil BJ
    Acad Radiol; 1996 Apr; 3 Suppl 1():S19-20. PubMed ID: 8796500
    [No Abstract]   [Full Text] [Related]  

  • 35. The scientific basis for coverage decisions by third-party payers.
    Towery OB; Perry S
    JAMA; 1981 Jan; 245(1):59-61. PubMed ID: 6776306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.
    George JC; Popma JJ
    JACC Cardiovasc Interv; 2009 Sep; 2(9):894-6. PubMed ID: 19778781
    [No Abstract]   [Full Text] [Related]  

  • 37. State model: Oregon. The ups and downs of Oregon's rationing plan.
    Fox DM; Leichter HM
    Health Aff (Millwood); 1993; 12(2):66-70. PubMed ID: 8375824
    [No Abstract]   [Full Text] [Related]  

  • 38. Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis.
    Torbica A; Fornaro G; Tarricone R; Drummond MF
    Value Health; 2020 Jan; 23(1):17-24. PubMed ID: 31952668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology assessment & policy determination.
    Lively L; Hugh J; Gomez B; Desai A
    Adm Radiol J; 1996 May; 15(5):50-1. PubMed ID: 10158657
    [No Abstract]   [Full Text] [Related]  

  • 40. The political economy of rationing health care in England and the US: the 'accidental logics' of political settlements.
    Bevan G; Brown LD
    Health Econ Policy Law; 2014 Jul; 9(3):273-94. PubMed ID: 24759205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.